Learn to Customize Your Own Options Trading Strategy
This guide will help you evaluate and analyze your trading plan to create a custom options trading strategy tailored to your risk profile and market outlook. Learn how to take your trading to the next level.
Download your FREE Options Strategy Guide Today!
pixel

LABP Insider Trading (Landos Biopharma)

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): $30,305,826.42
Insider Selling (Last 12 Months): $0.00

Landos Biopharma Insider Trading History Chart

This chart shows the insider buying and selling history at Landos Biopharma by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Landos Biopharma Share Price & Price History

Current Price: $13.87
Price Change: Price Decrease of -0.9 (-6.09%)
As of 10/22/2021 04:55 PM ET

This chart shows the closing price history over time for LABP up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
A $25T industry
China is the world's FinTech leader. This firm may transform a $25T industry.
See this firm now.

Landos Biopharma Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/8/2021Perceptive Advisors LlcDirectorBuy1,250,000$16.00$20,000,000.00View SEC Filing Icon  
2/5/2021Konstantin PoukalovDirectorBuy27,453$11.14$305,826.42View SEC Filing Icon  
2/4/2021Rtw Investments, LpMajor ShareholderBuy625,000$16.00$10,000,000.00View SEC Filing Icon  
See Full Table
Insider Buying at Landos Biopharma?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Landos Biopharma and related companies.

SEC Filings (Institutional Ownership Changes) for Landos Biopharma (NASDAQ:LABP)

56.63% of Landos Biopharma stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at LABP by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Landos Biopharma Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
10/22/2021Strs Ohio11,400$0.17M0.0%+660.0%0.028%Search for SEC Filing on Google Icon
8/23/2021Morgan Stanley6,912$81K0.0%+1,337.0%0.017%Search for SEC Filing on Google Icon
8/17/2021Wells Fargo & Company MN9,526$0.11M0.0%+382.6%0.024%Search for SEC Filing on Google Icon
8/17/2021Logos Global Management LP899,106$10.39M0.9%+22.5%2.241%Search for SEC Filing on Google Icon
8/16/2021Bank of America Corp DE11,223$0.13M0.0%-43.7%0.028%Search for SEC Filing on Google Icon
8/16/2021Tudor Investment Corp Et Al17,793$0.21M0.0%-71.3%0.044%Search for SEC Filing on Google Icon
8/16/2021Morgan Stanley6,912$81K0.0%+1,337.0%0.017%Search for SEC Filing on Google Icon
8/16/2021State Street Corp92,367$1.07M0.0%+88.1%0.230%Search for SEC Filing on Google Icon
8/13/2021Botty Investors LLC122,781$1.42M0.5%+26.0%0.306%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC127,518$1.47M0.0%+15.3%0.318%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.305,185$3.52M0.0%+61.9%0.761%Search for SEC Filing on Google Icon
8/11/2021Bank of New York Mellon Corp14,029$0.16M0.0%+37.8%0.035%Search for SEC Filing on Google Icon
8/11/2021BlackRock Inc.294,043$3.40M0.0%+14.7%0.733%Search for SEC Filing on Google Icon
5/27/2021Davidson Kempner Capital Management LP50,000$0.48M0.0%N/A0.125%Search for SEC Filing on Google Icon
5/19/2021Logos Global Management LP734,000$7.07M0.7%N/A1.830%Search for SEC Filing on Google Icon
5/19/2021Squarepoint Ops LLC15,361$0.15M0.0%N/A0.038%Search for SEC Filing on Google Icon
5/18/2021Zimmer Partners LP90,100$0.87M0.0%N/A0.225%Search for SEC Filing on Google Icon
5/18/2021Tudor Investment Corp Et Al61,899$0.60M0.0%N/A0.154%Search for SEC Filing on Google Icon
5/18/2021Orbimed Advisors LLC681,000$6.56M0.1%N/A1.697%Search for SEC Filing on Google Icon
5/18/2021Davidson Kempner Capital Management LP50,000$0.48M0.0%N/A0.125%Search for SEC Filing on Google Icon
5/18/2021Old Well Partners LLC18,316$0.18M0.1%N/A0.046%Search for SEC Filing on Google Icon
5/18/2021California State Teachers Retirement System9,518$92K0.0%N/A0.024%Search for SEC Filing on Google Icon
5/17/2021Deerfield Management Company L.P. Series C450,000$4.33M0.1%N/A1.122%Search for SEC Filing on Google Icon
5/17/2021Perceptive Advisors LLC17,960,839$159.69M2.0%N/A44.770%Search for SEC Filing on Google Icon
5/17/2021Woodline Partners LP213,335$2.05M0.0%N/A0.532%Search for SEC Filing on Google Icon
5/17/2021Caas Capital Management LP40,000$0.39M0.0%N/A0.100%Search for SEC Filing on Google Icon
5/17/2021Nuveen Asset Management LLC10,219$98K0.0%N/A0.025%Search for SEC Filing on Google Icon
5/17/2021Sphera Funds Management LTD.70,000$0.67M0.1%N/A0.174%Search for SEC Filing on Google Icon
5/14/2021Laurion Capital Management LP10,000$96K0.0%N/A0.025%Search for SEC Filing on Google Icon
5/14/2021RTW Investments LP4,275,722$38.33M0.6%N/A10.658%Search for SEC Filing on Google Icon
5/14/2021Monashee Investment Management LLC91,309$0.88M0.1%N/A0.228%Search for SEC Filing on Google Icon
5/13/2021Bank of New York Mellon Corp10,182$98K0.0%N/A0.025%Search for SEC Filing on Google Icon
5/13/2021Botty Investors LLC97,477$0.94M0.3%N/A0.243%Search for SEC Filing on Google Icon
5/12/2021Northern Trust Corp74,359$0.72M0.0%N/A0.185%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC110,559$1.06M0.0%N/A0.276%Search for SEC Filing on Google Icon
5/12/2021Ensign Peak Advisors Inc125,000$1.20M0.0%N/A0.312%Search for SEC Filing on Google Icon
5/12/2021JPMorgan Chase & Co.375,021$3.61M0.0%N/A0.935%Search for SEC Filing on Google Icon
5/11/2021Teacher Retirement System of Texas10,000$96K0.0%N/A0.025%Search for SEC Filing on Google Icon
5/11/2021New York State Common Retirement Fund7,300$70K0.0%N/A0.018%Search for SEC Filing on Google Icon
5/7/2021BlackRock Inc.256,290$2.47M0.0%N/A0.639%Search for SEC Filing on Google Icon
5/7/2021American International Group Inc.3,677$35K0.0%N/A0.009%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Landos Biopharma, Inc., a clinical-stage biopharmaceutical company, discovers and develops oral therapeutics for patients with autoimmune diseases. Its lead product candidate in development is BT-11, an oral lanthionine synthetase C-like protein 2 (LANCL2) agonist for the treatment of ulcerative colitis (UC), Crohn's disease (CD), and inflammatory bowel diseases. The company also develops NX-13, a gut-restricted oral therapeutic that targets NOD-like receptor X1, a mitochondria-associated receptor associated with the modulation of inflammatory cytokines for UC and CD; and PX-69, an oral PLXDC2 agonist for the treatment of diabetic nephropathy and rheumatoid arthritis. Landos Biopharma, Inc. was incorporated in 2017 and is headquartered in Blacksburg, Virginia.
Read More on Landos Biopharma

Today's Range

Now: $13.87
Low: $13.84
High: $14.57

50 Day Range

MA: $14.38
Low: $12.98
High: $15.77

52 Week Range

Now: $13.87
Low: $8.82
High: $16.99

Volume

1,932 shs

Average Volume

77,149 shs

Market Capitalization

$556.46 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Landos Biopharma?

Landos Biopharma's top insider investors include:
  1. Konstantin Poukalov (Director)
  2. Perceptive Advisors Llc (Director)
  3. Rtw Investments, Lp (Major Shareholder)

Who are the major institutional investors of Landos Biopharma?

Landos Biopharma's top institutional investors include:
  1. Strs Ohio — 0.03%

Which institutional investors are buying Landos Biopharma stock?

Within the previous quarter, LABP stock was bought by institutional investors including:
  1. Strs Ohio
Within the last year, these company insiders have bought Landos Biopharma stock:
  1. Konstantin Poukalov (Director)
  2. Perceptive Advisors Llc (Director)
  3. Rtw Investments, Lp (Major Shareholder)
The plant-based revolution is here.
This yet-to-be public firm has $85B potential to transform plant-based foods.
Investors must see